Ebola Outbreak Leads to Lassa Fever Vaccine Development
Scientists reveal how the 2016 Ebola crisis accelerated work on a Lassa fever vaccine, now in human trials. Learn about the Oxford/CEPI project and plans for West Africa, including Nigeria.
Scientists reveal how the 2016 Ebola crisis accelerated work on a Lassa fever vaccine, now in human trials. Learn about the Oxford/CEPI project and plans for West Africa, including Nigeria.
The Federal Government has trained Nigerian scientists in mRNA technology to boost local malaria vaccine production. This initiative aims to enhance health security and reduce import dependence.
NIMR confirms the first detection of the invasive Anopheles stephensi mosquito in Gombe, Nigeria. This urban-adapted vector poses a major new threat to malaria control efforts nationwide. Read more.
NIPRD warns Nigeria's reliance on a single WHO-prequalified antimalarial limits local manufacturing. The institute trains pharma firms to tap into the $161m global market, urging tax reliefs and incentives.
Bayelsa State launches a road show to sensitize residents ahead of the Measles-Rubella vaccination campaign from January 20-29, 2026. Health officials urge parents to vaccinate children aged 9-15 months.
Edo Deputy Governor Dennis Idahosa directs the strengthening of rural Primary Healthcare Centres and announces a major Measles-Rubella vaccine campaign for 2026, targeting all children aged 9 months to 14 years.
Edo Deputy Governor Dennis Idahosa mandates stronger rural primary healthcare. Plans 2026 Measles-Rubella vaccine campaign for children 9 months to 14 years. Read more.
ACE Strategy and Consults reveals its 2025 success, reaching millions of Nigerian children through immunisation and digital enumeration. Discover the strategies behind this public health milestone.
Lagos State kicks off a 4-day second phase polio vaccination campaign targeting children under five. Health teams will visit homes and public spaces to administer the safe nOPV2 vaccine.
Nigeria and other endemic nations applaud the start of a first-in-human clinical trial for a Lassa fever vaccine in Oxford, marking a critical step against the deadly disease. Read more.
A US vaccine advisory panel, now led by skeptics, is reviewing the decades-old practice of giving hepatitis B shots to newborns. Experts warn this could cause preventable deaths and lower immunization rates. Read the full analysis.
A groundbreaking twice-yearly HIV-prevention injection with over 99.9% efficacy begins rollout in Southern Africa, offering new hope in the fight against the virus. Read the full story.
As Nigeria battles a worsening cholera outbreak with over 22,000 cases, the FG sought emergency vaccine allocations four times. Learn about the global response and impact.
Hacey Health Initiative raises alarm as Nigeria accounts for over 39% of Africa's malaria deaths. Vulnerable groups at highest risk. Learn about intervention efforts.
Diaspora Solution Group Nigeria launches groundbreaking research using CRISPR technology to reduce female Anopheles mosquito breeding. Join the fight against malaria on December 20, 2025.
Diaspora Solution Group Nigeria launches groundbreaking research to reduce female Anopheles mosquito breeding using CRISPR technology. Join the fight against malaria in Osogbo this December.
Novak Djokovic accepts Piers Morgan's apology for calling him a 'liar and cheat' during 2021 Australian Open Covid vaccine controversy. Read the full story.
Global pharmaceutical giant Pfizer experiences significant profit decline amid falling COVID-19 product sales. Analysis of impact on Nigerian healthcare market and future outlook.